Comparison of Fatal or Irreversible Events With Extended‐Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy

BACKGROUND: Extended‐duration betrixaban showed a significant reduction in venous thromboembolism in the APEX trial (Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study). Given the variable clinical impact of different efficacy and safety events, one approach to assess net cli...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Heart Assoc
Hlavní autoři: Gibson, C. Michael, Korjian, Serge, Chi, Gerald, Daaboul, Yazan, Jain, Purva, Arbetter, Douglas, Goldhaber, Samuel Z., Hull, Russel, Hernandez, Adrian F., Lopes, Renato D., Gold, Alex, Cohen, Alexander T., Harrington, Robert A.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2017
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5586307/
https://ncbi.nlm.nih.gov/pubmed/28698258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.006015
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky